Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
This is a shot in the arm for the vaccine manufacturers
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
Subscribe To Our Newsletter & Stay Updated
